The Biodistribution of 1-L-(2 Deoxy-2,- 18 Fluoroarabinofuranosyl) Cytosine ([18F]L-FAC) in Healthy Subjects and Patients With Cancer, Autoimmune and Inflammatory Diseases

Analysis of Diphenylcyclopropenone (DPCP) in Normals

NCT01452594 ·Status: COMPLETED

Bispecific Antibody in Finding Tumor Cells in Patients With Colorectal Cancer

NCT00895323 ·Status: UNKNOWN ·Phase: PHASE1

NOTION: iN-home Sampling Of cyTokines in ImmunOtherapy patieNts

NCT04960059 ·Status: COMPLETED

Exploring Relevant Immune-based Biomarkers and Circulating Tumor Cells During Treatment With Immunotherapy in Genitourinary Malignancies (CTC Immune Based Biomarkers)

NCT02978118 ·Status: ACTIVE_NOT_RECRUITING

Immune-Related Adverse Events and Associated Biomarkers in Patients Receiving Cancer Immunotherapy

NCT06089967 ·Status: COMPLETED

Cellular Immunotherapy Study With Autologous Dendritic Cells Loaded With Oncofetal Antigen/iLRP in Patients With Metastatic Breast Cancer

NCT00879489 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

CT Antigen TCR-redirected T Cells for Ovarian Cancer.

NCT01567891 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Biospecimen Collection Study of Leukapheresis-Derived Circulating Tumor Cells, Immune Cells, and Progenitor Cells.

NCT00571389 ·Status: RECRUITING

Dendritic Cell Vaccination During Lymphoid Reconstruction

NCT00313508 ·Status: COMPLETED ·Phase: PHASE1

In Vitro Studies of Immunological and Stem Cell Function in Peripheral Blood Mononuclear Cells in Patients

NCT00001336 ·Status: COMPLETED

Improving the Immune System With Human IL-7 Vaccine in Older Subjects Who Have Had Chemotherapy

NCT01339000 ·Status: TERMINATED ·Phase: PHASE2

Long-Term Follow-up Study of Subjects Treated With Autologous T Cells Using the Sleeping Beauty System to Express TCRs

NCT05292859 ·Status: COMPLETED

Identification of Pathways to Mitigate Immune-Related Adverse Events With Cancer Immunotherapy

NCT04283539 ·Status: RECRUITING

Single Center Study Of N-803 Stimulation On Expansion, Enrichment, Proliferation Of Natural Killer Cells Collected By Apheresis

NCT06040918 ·Status: COMPLETED ·Phase: PHASE1

A Phase I Cancer Vaccine Study for Patients With Metastatic Breast Cancer

NCT00715832 ·Status: UNKNOWN ·Phase: PHASE1

LANDscape MApping of Epitopes and T Cell Receptors for Selected Cancers

NCT04665388 ·Status: RECRUITING

Safety and Effectiveness of a Vaccine for Prostate Cancer That Uses Each Patients' Own Immune Cells.

NCT00289341 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Natural Killer Cells Functions, Tumoral Escape to Immune System and Regulation of Natural Cytotoxixity Receptors in Haematological Malignancies

NCT01915992 ·Status: UNKNOWN ·Phase: NA

Immune Response in Cervical Lymph Nodes of Patients With Head and Neck Cancer

NCT07131566 ·Status: RECRUITING

VRC 900: Evaluation of Tissue-Specific Immune Responses in Adults 18 Years of Age and Older

NCT01132859 ·Status: RECRUITING

Specialized Immune Cells (nCTLs) and a Vaccine (Alpha-type-1 Polarized Dendritic Cells) in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

NCT03735589 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2

Vaccine Therapy With or Without Cryosurgery in Treating Patients With Residual, Relapsed, or Refractory B-Cell Non-Hodgkin Lymphoma

NCT01239875 ·Status: COMPLETED ·Phase: EARLY_PHASE1

Predictive Markers of Immune-related Adverse Events in Patients Treated With Immune Stimulatory Drugs

NCT03984318 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

Characterization of the Microbiome in Cutaneous T Cell Lymphoma Skin Lesions Before and After Use of APR-TD011® (RLF-TD011®) Spray Solution

NCT05728879 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1

An Experimental Medicine Clinical Study to Compare Peripheral Immune System From Subjects Without Cancer Diagnosis and Patients With Solid Tumours.

NCT05133128 ·Status: TERMINATED ·Phase: NA